Squarepoint Ops LLC Gh Research PLC Transaction History

Squarepoint Ops LLC

  • $62.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$5.26 - $11.04 $217,127 - $455,720
41,279 New
41,279 $239,000
Q3 2021

Nov 15, 2021
SELL
$16.51 - $23.68 $297,180 - $426,240
-18,000 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$19.25 - $21.73 $346,500 - $391,140
18,000 New
18,000 $391,000

Others Institutions Holding GHRS

# of Institutions
32
Shares Held
27.8M
Call Options Held
2.8K
Put Options Held
3.8K
View Full List

About GH Research PLC

GHRS Quotes by TradingView
  • Ticker GHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,020,800
  • Market Cap $446M
  • Description
  • GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...
More about GHRS
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email